Parallax Volatility Advisers
CRL icon

Parallax Volatility Advisers’s Charles River Laboratories CRL Stock Holding History

Parallax Volatility Advisers’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80
Closed -$19.1K – 1919
2023
Q4 		$18.9K Buy
80
+3
+4% +$590 ﹤0.01% 1994
2023
Q3 		$15.1K Buy
+77
New +$15.8K ﹤0.01% 2097
2022
Q4 		– Sell
-558
Closed -$110K – 2938
2022
Q3 		$110K Buy
+558
New +$120K ﹤0.01% 2455
2021
Q1 		– Sell
-32,974
Closed -$8.24M – 3297
2020
Q4 		$8.24M Buy
32,974
+32,739
+13,931% +$7.8M 0.01% 1180
2020
Q3 		$53K Buy
+235
New +$48.8K ﹤0.01% 2840
2019
Q2 		– Sell
-2,954
Closed -$429K – 2665
2019
Q1 		$429K Buy
+2,954
New +$388K ﹤0.01% 1594

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Parallax Volatility Advisers's CRL Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 80 shares — an estimated $19.1K sold.

Parallax Volatility Advisers first reported a position in CRL in Q1 2019 and held it in 6 quarters. The position peaked at $8.24M in Q4 2020. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 80 Charles River Laboratories shares in Q1 2024, an estimated $19.1K.
  • Parallax Volatility Advisers first reported a position in Charles River Laboratories in Q1 2019 and held it in 6 quarters.
  • Parallax Volatility Advisers's Charles River Laboratories position peaked at $8.24M in Q4 2020.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.